Shelton, Richard C.

Assessing the effects of bupropion SR on mood dimensions of depression

Tomarken, A. J., Dichter, G. S., Freid, C., Addington, S., & Shelton, R. C. (2004) · Journal of Affective Disorders

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 139

DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation

Roy, B., Shelton, R. C., & Dwivedi, Y. (2017) · Journal of Psychiatric Research

Epigenetics and DNA MethylationStress Responses and Cortisol

Cited by 139

Psychiatric profile and attention deficits in postural tachycardia syndrome

Raj, V, Haman, K. L., Raj, S. R., Byrne, D., Blakely, R. D., Biaggioni, I., Robertson, D., & Shelton, R. C. (2009) · Journal of Neurology, Neurosurgery & Psychiatry

Cardiovascular Syncope and Autonomic DisordersPsychosomatic Disorders and Their Treatments

Cited by 131

Sudden gains in cognitive therapy of depression and depression relapse/recurrence

Tang, T. Z., DeRubeis, R. J., Hollon, S. D., Amsterdam, J., & Shelton, R. (2007) · Journal of Consulting and Clinical Psychology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 129

Presenting characteristics of depressed outpatients as a function of recurrence: Preliminary findings from the STAR*D clinical trial

Hollon, S. D., Shelton, R. C., Wisniewski, S., Warden, D., Biggs, M. M., Friedman, E. S., Husain, M., Kupfer, D. J., Nierenberg, A. A., Petersen, T. J., et al. (2006) · Journal of Psychiatric Research

Treatment of Major DepressionMental Health Treatment and Access

Cited by 120

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Keller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 116

cAMP-dependent protein kinase activity in major depression

Shelton, R. C., Mainer, D. H., & Sulser, F. (1996) · American Journal of Psychiatry

Treatment of Major DepressionStress Responses and Cortisol

Cited by 105

Effects of a safe person on induced distress following a biological challenge in panic disorder with agoraphobia.

Carter, M. M., Hollon, S. D., Carson, R., & Shelton, R. C. (1995) · Journal of Abnormal Psychology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychosomatic Disorders and Their Treatments

Cited by 98

Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial

Domany, Y., Shelton, R. C., & McCullumsmith, C. B. (2020) · Depression and Anxiety

Treatment of Major DepressionSuicide and Self-Harm Studies

Cited by 84

Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression.

Leykin, Y., Amsterdam, J. D., DeRubeis, R. J., Gallop, R., Shelton, R. C., & Hollon, S. D. (2007) · Journal of Consulting and Clinical Psychology

Treatment of Major DepressionPsychotherapy Techniques and Applications

Cited by 82

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

Nierenberg, A. A., McElroy, S. L., Friedman, E. S., Ketter, T. A., Shelton, R. C., Deckersbach, T., McInnis, M. G., Bowden, C. L., Tohen, M., Kocsis, J. H., et al. (2016) · The Journal of Clinical Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 81

Sustained amygdala response to both novel and newly familiar faces characterizes inhibited temperament

Blackford, J. U., Avery, S. N., Cowan, R. L., Shelton, R. C., & Zald, D. H. (2011) · Social Cognitive and Affective Neuroscience

Face Recognition and PerceptionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 70

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT study

Kocsis, J. H., Thase, M. E., Trivedi, M. H., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Dunner, D. L., Hirschfeld, R. M. A., et al. (2007) · The Journal of Clinical Psychiatry

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 67

Amygdala temporal dynamics: temperamental differences in the timing of amygdala response to familiar and novel faces

Blackford, J. U., Avery, S. N., Shelton, R. C., & Zald, D. H. (2009) · BMC Neuroscience

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesFace Recognition and Perception

Cited by 65

Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial

Janik, A., Qiu, X., Lane, R., Popova, V., Drevets, W. C., Canuso, C. M., Macaluso, M., Mattingly, G. W., Shelton, R. C., Zajecka, J. M., et al. (2025) · JAMA Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 54

Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial

DeRubeis, R. J., Zajecka, J., Shelton, R. C., Amsterdam, J. D., Fawcett, J., Xu, C., Young, P. R., Gallop, R., & Hollon, S. D. (2020) · JAMA Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 48

Steps Following Attainment of Remission: Discontinuation of Antidepressant

Shelton, R. C. (2001) · The Primary Care Companion For CNS Disorders

Treatment of Major DepressionMental Health Treatment and Access

Cited by 43

Childhood maltreatment increases the risk for visceral obesity

Li, L., Chassan, R. A., Bruer, E. H., Gower, B. A., & Shelton, R. C. (2015) · Obesity

Child Abuse and TraumaStress Responses and Cortisol

Cited by 41

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression

Shelton, R. C., Andorn, A. C., Mallinckrodt, C. H., Wohlreich, M. M., Raskin, J., Watkin, J. G., & Detke, M. J. (2007) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 39

Gains in employment status following antidepressant medication or cognitive therapy for depression

Fournier, J. C., DeRubeis, R. J., Amsterdam, J., Shelton, R. C., & Hollon, S. D. (2015) · British Journal of Psychiatry

Treatment of Major DepressionPsychotherapy Techniques and Applications

Cited by 36

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder

Köhler, O., Sylvia, L. G., Bowden, C. L., Calabrese, J. R., Thase, M., Shelton, R. C., McInnis, M., Tohen, M., Kocsis, J. H., Ketter, T. A., et al. (2017) · Australian & New Zealand Journal of Psychiatry

Bipolar Disorder and TreatmentTryptophan and brain disorders

Cited by 33

Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder

Shelton, R. C., Parikh, S. V., Law, R. A., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Macaluso, M., et al. (2020) · Psychiatry Research

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 31

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

Rothschild, A. J., Parikh, S. V., Hain, D., Law, R., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Shelton, R. C., et al. (2021) · Psychiatry Research

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 20

Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder.

Köhler-Forsberg, O., Sylvia, L., Deckersbach, T., Ostacher, M. J., McInnis, M., Iosifescu, D., Bowden, C., McElroy, S., Calabrese, J., Thase, M., et al. (2018) · Acta Neuropsychiatrica

Bipolar Disorder and TreatmentTryptophan and brain disorders

Cited by 15